Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Siera Shiyou

Physician Assistant Jackson, MS Physician Assistant

NPI 1760956247 CMS profile 10738876

501 Marshall St Ste 104, Jackson, MS 39202

Open in the dashboard

General payments

$11,703

199 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Siera Shiyou of Jackson, MS is reported in the CMS Open Payments database as having received $11,703 across 199 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $984 13
2024 General $2,397 39
2023 General $3,229 68
2022 General $3,621 54
2021 General $1,473 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Siera Shiyou
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Siera Shiyou were reported at $984. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Siera Shiyou Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,473 $132 $37–$438 $132
2022 $3,621 $155 $48–$522 $149
2023 $3,229 $167 $52–$557 $160
2024 $2,397 $178 $55–$600 $164
2025 $984 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $7,125 123 payments
  2. Medtronic, Inc. $3,185 48 payments
  3. Silk Road Medical, Inc. $567 7 payments
  4. LeMaitre Vascular, Inc. $140 4 payments
  5. Kerecis Limited $136 1 payment
  6. AngioDynamics, Inc. $122 2 payments
  7. Philips Electronics North America Corporation $121 1 payment
  8. Boston Scientific Corporation $90 1 payment
  9. Bard Peripheral Vascular, Inc. $65 4 payments
  10. Cordis US Corp. $65 4 payments
  11. Other $87 4 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,638 196 payments
  2. Travel and Lodging $1,065 3 payments
Products named General payments · program years 2021–2025
  1. GORE VIABAHN VBX Balloon Expandable Endo $1,490 21 payments
  2. VENASEAL $1,123 5 payments
  3. GORE ACUSEAL Vascular Graft $1,107 16 payments
  4. ENDURANT IIS $790 9 payments
  5. GORE VIABAHN Endoprosthesis $781 13 payments
  6. GORE PROPATEN Vascular Graft $732 10 payments
  7. EXCLUDER Conformable AAA Endoprosthesis with Active Control $598 17 payments
  8. ENROUTE Transcarotid Stent $567 7 payments
  9. ENROUTE Transcarotid Neuroprotection System $567 7 payments
  10. GORE TAG Thoracic Branch Endoprosthesis $521 10 payments
  11. Other $4,830 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

50

Median for Physician Assistant: 241

Drug cost

$10,094

Median for Physician Assistant: $4,110

Branded share of claims

100%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 14 $9,906
Clopidogrel Clopidogrel Bisulfate Brand 36 $188

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$8,293

Medicare's payments for the services billed

Medicare patients

153

Average age 77

Services billed

181

76 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Ischemic heart disease 59%
Diabetes 53%
Chronic kidney disease 44%
Heart failure 38%
COPD 29%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

199 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record